Results 101 to 110 of about 43,286 (202)
IntroductionMoyamoya disease (MMD) commonly presents with cerebral ischemia or hemorrhage. Revascularization surgery, including direct, indirect, and combined bypasses, remains the mainstay of MMD treatment aiming to reduce stroke recurrence.
Sha Wang +4 more
doaj +1 more source
BackgroundAnemia is considered a risk factor for cardiovascular disease. However, there is little evidence regarding the relationship between hemoglobin (HB) and cerebral infarction after revascularization in patients with moyamoya disease (MMD).
Haitao Wu +5 more
doaj +1 more source
Case Report: Successful Cerebral Revascularization and Cardiac Transplant in a 16-Year-Old Male With Syndromic BRCC3-Related Moyamoya Angiopathy. [PDF]
Pyra P +9 more
europepmc +1 more source
Immediate versus delayed treatment for recently symptomatic carotid artery stenosis
BACKGROUND: The timing of surgery for recently symptomatic carotid artery stenosis remains controversial. Early cerebral revascularization may prevent a disabling or fatal ischemic recurrence, but it may also increase the risk of hemorrhagic ...
Vladimir Vasconcelos +3 more
doaj +1 more source
Optimal Cerebral Protection Confirmed by Transcranial Doppler During Transcarotid Artery Revascularization [PDF]
R Vernes +3 more
openalex +1 more source
Middle cerebral artery revascularization: anatomical studies and considerations on the anastomosis site [PDF]
Murilo S. Meneses +5 more
openalex +1 more source
Exploration of the risk factor for infarction after revascularization in moyamoya disease
Objective Despite revascularization has been proven to be the optimal choice of moyamoya disease (MMD), many complications may occur in this context.. This study aimed to analyse the risk factors for new or expanded symptomatic infarctions of patients ...
Tao Sun +8 more
doaj +1 more source
Indication of Revascularization for Cerebral Main Trunk Occlusion Using MR Diffusion Weighted Image.
Tohru Inagaki +5 more
openalex +2 more sources
Cerebral hyperperfusion syndrome (CHS) is a serious post-procedural complication of carotid artery stenting (CAS). The pathophysiological mechanisms of CHS in the absence of arterial hypertension (AH) remain only partially understood.
Matija Zupan +3 more
doaj +1 more source

